Havent been updated with the melanoma trial with keytruda/ MSD...

  1. 2,368 Posts.
    lightbulb Created with Sketch. 19
    Havent been updated with the melanoma trial with keytruda/ MSD but the following

    Phase I/II clinical trial (QBC46-H03) evaluating the optimal dose of our lead oncology molecule tigilanol tiglate in patients with head and neck squamous cell carcinoma (HNSCC)

    cheers
    Last edited by Rajenp5: 15/03/22
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.